Neuropsychiatric Disease and Treatment

SJR Rank #5,342H-index: 106SJR: 0.947Best quartile: Q2Open AccessAPC: US$2,836Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Dove Medical Press Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Psychiatry and Mental HealthQ2
  • Biological PsychiatryQ3

Areas: Medicine · Neuroscience

Most published research topics

Schizophrenia research and treatmentTreatment of Major DepressionTryptophan and brain disordersBipolar Disorder and TreatmentAttention Deficit Hyperactivity DisorderAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesDementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and TreatmentsEpilepsy research and treatmentAutism Spectrum Disorder Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025070140210280

Detailed Information

ISSN

1178-2021

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.10

References per Document

52.39

Coverage

2001, 2006-2026

Scope

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

Metrics from SCImago Journal Rank 2025. View on SCImago